American Portfolios Advisors’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
AC
KCM
AIC
GIPM
FLAM
American Portfolios Advisors's OPRX Position: Q3 2022 in Review
American Portfolios Advisors sold out of OptimizeRx (OPRX) in Q3 2022, closing a stake of 146 shares — an estimated $4K sold.
American Portfolios Advisors first reported a position in OPRX in Q1 2021 and held it in 6 quarters. The position peaked at $12.5K in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q3 2022.
- American Portfolios Advisors reported no remaining OptimizeRx position as of Q3 2022 after selling out during the quarter.
- American Portfolios Advisors sold 146 OptimizeRx shares in Q3 2022, an estimated $4K.
- American Portfolios Advisors first reported a position in OptimizeRx in Q1 2021 and held it in 6 quarters.
- American Portfolios Advisors's OptimizeRx position peaked at $12.5K in Q3 2021.
- 128 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.